These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10394018)

  • 21. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.
    Atkinson BJ; Lewis RE; Kontoyiannis DP
    Med Mycol; 2008 Sep; 46(6):541-6. PubMed ID: 19180749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New options for treatment of candidaemia in critically ill patients.
    Ruhnke M; Hartwig K; Kofla G
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():46-54. PubMed ID: 18430129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
    White MH; Bowden RA; Sandler ES; Graham ML; Noskin GA; Wingard JR; Goldman M; van Burik JA; McCabe A; Lin JS; Gurwith M; Miller CB
    Clin Infect Dis; 1998 Aug; 27(2):296-302. PubMed ID: 9709879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipid derivatives of amphotericin B in treatment of systemic candidiasis].
    Rosenthal E
    Presse Med; 2000 Mar; 29(8):428. PubMed ID: 10738509
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant].
    Emminger W; Innerhofer A; Helfert A; Kummer M; Gadner H
    Padiatr Padol; 1992; 27(4):97-9. PubMed ID: 1408291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphotericin B lipid complex and respiratory distress.
    Shuster J
    Nursing; 1999 Mar; 29(3):70. PubMed ID: 10205512
    [No Abstract]   [Full Text] [Related]  

  • 29. The population pharmacokinetics of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
    Amantea MA; Bowden RA; Forrest A; Working PK; Newman MS; Mamelok RD
    Chemotherapy; 1999 Jun; 45 Suppl 1():48-53. PubMed ID: 10394021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
    Bowden R; Chandrasekar P; White MH; Li X; Pietrelli L; Gurwith M; van Burik JA; Laverdiere M; Safrin S; Wingard JR
    Clin Infect Dis; 2002 Aug; 35(4):359-66. PubMed ID: 12145716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases.
    Agustin J; Lacson S; Raffalli J; Aguero-Rosenfeld ME; Wormser GP
    Clin Infect Dis; 1999 Sep; 29(3):686-7. PubMed ID: 10530471
    [No Abstract]   [Full Text] [Related]  

  • 32. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B colloidal dispersion: an improved antifungal therapy.
    Guo LS
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):149-63. PubMed ID: 11311990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broviac catheter-related candidemia.
    Castagnola E; Marazzi MG; Tacchella A; Giacchino R
    Pediatr Infect Dis J; 2005 Aug; 24(8):747. PubMed ID: 16094241
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
    Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
    Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.
    Oppenheim BA; Herbrecht R; Kusne S
    Clin Infect Dis; 1995 Nov; 21(5):1145-53. PubMed ID: 8589134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice.
    van Deventer AJ; Goessens WH; van Belkum A; van Etten EW; van Vliet HJ; Verbrugh HA
    J Clin Microbiol; 1996 Jan; 34(1):25-8. PubMed ID: 8748265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia.
    Cetin H; Yalaz M; Akisu M; Hilmioglu S; Metin D; Kultursay N
    Pediatr Int; 2005 Dec; 47(6):676-80. PubMed ID: 16354223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal amphotericin B in neonates with invasive candidiasis.
    Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
    Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.